RegMed Forum 2017 - Advanced Disease Models: From 3D Cell Culture and 3D Bioprinting Towards Multi-Organ Chips

Potsdam Colloquium on Bioanalysis

November 5


Program Overview

Sessionübersicht - Colloquium

Detailed Schedule


08:45 - 09:15
09:15 - 09:30
Welcome Address
Frank Bier, Fraunhofer IZI - Department of Biosystem Integration & Automation, Potsdam-Golm, Germany
09:30 - 10:10
Opening Lecture: Non-Invasive Trends for Next Generation Analytics
Maximilian Fleischer, Siemens AG - Corporate Technology, München, Germany
10:10 - 10:40
Coffee Break



Light, the basis of all seeing is a natural phenomenon for humans. It enables rapid, sensitive and contact-free measuring and is therefore an ideal tool for the enlightenment of biological processes. In this context, biophotonics – the application of light-based technologies in medicine and life sciences – promises important and quick solutions, as well as new insights into biological processes on the way to improved health and quality of life. In this session, both, innovative optical technologies for diagnosis and their enormous potential in the fight against diseases will be presented.

Moderation: Gerrit Roessler, Berlin Partner for Business and Technology
10:40 - 11:10
Keynote: Optical and Multi-Modal Methodologies for Quantitative In Vitro-Diagnostics
Joerg Neukammer, Physikalisch-Technische Bundesanstalt, Berlin, Germany
11:10 - 11:30
MIKROQUANT - Quantitative Tumor Diagnostics by Stimulated Raman Scattering Microscopy
Andreas Volkmer, Institute of Physics, University of Stuttgart, Germany
11:30 - 11:50
Rapid Characterisation of Pathogenic Microorganisms by Infrared and Raman Microspectroscopy
Peter Lasch, Robert Koch Institute, Berlin, Germany
11:50 - 12:10
Optical Spectroscopy with DNA Nanostructures
Ilko Bald, Institute of Chemistry - Physical Chemistry, University of Potsdam, Germany
12:15 - 13:15

Lunch Break &

Poster Session (in the conference hall)


Point-of-Care-Testing - Infectious Diseases

Infectious diseases are, besides cardiovascular and cancer diseases, the most common reason of death worldwide. The use of diagnostic technologies for rapid and reliable identification of pathogens becomes increasingly important. One category of diagnostic technologies — rapid point-of-care (POC) tests — offers a number of advantages compared to other diagnostic approaches. POC diagnostics enable patients‘ rapid treatment and also have the potential to significantly impact the health care delivery system. In the session “POCT – Infectious Diseases” experts will share their views on POC in the clinical setting and give you an insight into the latest developments of innovative POC technologies.

Moderation: Stefan Roediger, BTU Cottbus-Senftenberg
13:15 - 13:45
Keynote: Point of Care Testing of Antimicrobial Resistance - Choosing the Right Biomarkers and Integrated Diagnostic Platforms to Address Unmet Global Needs
Till Bachmann, Division of Infection and Pathway Medicine, University of Edinburgh, United Kingdom
13:45 - 14:05
Point of Care Diagnostic of Emerging Infectious Diseases -  Time to Think Different
Frank Hufert, Medizinische Hochschule Brandenburg, Senftenberg, Germany
14:05 - 14:25
MDx Testing for Antibiotic Resistance: Changes & Challenges
Torsten Wassermann, Curetis AG, Holzgerlingen, Germany
14:25 - 14:45
Challenges in Sepsis Diagnostics and New Solution Approaches
Peter Schubert, R-Biopharm AG, Darmstadt, Germany
14:45 - 15:15
Coffee Break

M-Health & Diagnostics

The improvement of medical and technical progress is often associated with higher costs. But what about mobile-health - The use of classical mobile technologies, such as apps for smartphones promises a fundamental change in health care. Thus, m-health cannot only contribute to improved patient care and reduce costs, but also introduces new markets. In the session "M-Health & Diagnostics" you will learn more about the potential of m-health in the field of diagnostics and why the big breakthrough has not come yet.

Moderation: Frank Bier, Fraunhofer IZI - Department of Biosystem Integration & Automation
15:15 - 15:45
Keynote: M-Health as a Digital Therapy and Research Tool: Status Quo and Developments
Alexander Schachinger, EPatient RSD GmbH, Berlin, Germany
15:45 - 16:05
How Microelectronics Supports M-Health

Christian Wenger, IHP, Frankfurt (Oder), Germany

16:05 - 16:25
M-Health in the German Statutory Health Care System
Bernhard Tenckhoff, Kassenärztliche Bundesvereinigung, Berlin, Germany

16:25 - 16:45
Cardioexplorer - The First M-Diagnostic Test Proofed by Clinical Studies
Peter Ruff, Exploris AG, Zurich, Switzerland

End of Programme


closed since 5 Dec 2017
Registration 25 Apr – 5 Dec
Event 6 Dec
Language English
Costs free of charge
Venue Friedrichstraße 180
Berlin, Germany
Belarus 3
Belgium 1
China 1
Denmark 12
Egypt 1
France 2
Germany 120
Greece 1
Iran, Islamic Republic Of 1
Nigeria 1
Switzerland 3
United States 4
Total 150
Profile Views
Before Event156
After Event 112